2 ASX shares experts say 'buy'

BWX and City Chic are two ASX shares well-liked by brokers after a tough start to 2022.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • These two ASX shares are heavily buy-rated by brokers
  • BWX is a globally-growing natural beauty business
  • City Chic has a ‘world of curves’ strategy. It’s a retailer of apparel, footwear and accessories

The first three months of 2022 has not been kind to some ASX growth shares. But this could be opening up some opportunities, according to leading analysts.

While the ASX may not be known for having many global leaders, there are a few small caps that are quickly expanding their international footprint.

The experts reckon these two companies — after significant price declines year-to-date — could now be opportunities:

BWX Limited (ASX: BWX)

BWX is a natural beauty business with "market-leading" brands including Sukin, the number one natural skincare brand in Australian pharmacies, according to the company.

BWX also claims top pole positions on the US natural channel for Andalou Naturals, the number one facial skincare brand; and Mineral Fusion, the number one cosmetics brand. In addition, the company said Flora & Fauna was Australia's largest eco store and one of Australia's first B Corp businesses.

BWX recently acquired a 50.1% stake in Go-To Skincare for $89 million. In FY21, this business generated $36.8 million of revenue and $11.6 million of earnings before interest, tax, depreciation and amortisation (EBITDA). Go-To Skincare is expected to add to FY21 pro forma earnings per share (EPS) in the double digits when including $3 million of potential synergies.

The ASX share thinks that the Go-To acquisition is financially compelling and allows BWX to collaborate with one of Australia's leading skincare entrepreneurs and support its ongoing growth.

BWX continues to report overall growth. In the first six months of FY22, underlying revenue went up 26.5% to $106.9 million, while underlying net profit after tax (NPAT) rose 22.1% to $4.7 million.

It's currently rated as a buy by at least three brokers, including Citi, which has a lofty price target of $4.90. The broker thinks that the outlook is still promising for BWX.

City Chic Collective Ltd (ASX: CCX)

City Chic is a rapidly-growing retailer of clothing, footwear and accessories for plus-size women. It has different operations in different countries. City Chic is focused on Australia and New Zealand but has a growing presence globally. International operations include Evans, a UK-based company; Avenue, based in the United States; and Navabi, which is an EU-based company. It's expanding in several regions.

The ASX share is experiencing a lot of growth. In the first half of FY22, sales increased by 49.8% to $178.3 million. The company said revenue growth was supported by a strategic investment in inventory to proactively manage risks associated with global supply chain volatility and deliver continued growth.

It has launched new marketplace partnerships and expanded its brands and ranges across all geographies as part of its "world of curves" growth strategies.

In the first eight weeks of the second half of FY22, City Chic said it had continued to deliver revenue growth in the US, with UK and EU operations showing signs of recovery and getting closer to pre-acquisition levels.

In addition, the partner businesses across multiple geographies have continued to show growth. The company said it would launch new programs and new ranges with existing partners, as well as new partnerships over the rest of 2022.

City Chic is currently rated as a buy by at least five brokers, including UBS, which has a price target of $5. UBS thinks the ASX share can keep capturing more of the market.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BWX Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: What this leading broker is saying about Lynas shares

Is it bullish or bearish? Let's find out.

Read more »

share buyers, investors, happy investors
Broker Notes

Bell Potter's top ASX 200 holdings revealed

These are the top holdings in the broker's core portfolio.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Broker Notes

Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher

A leading broker forecasts more outperformance to come from this surging ASX rare earths stock.

Read more »

Miner with thumbs up at a mine.
Gold

2 ASX gold miners to buy for solid share price gains, according to Barrenjoey

The Africa-focused companies are deeply undervalued after recent sell-offs, the broker says.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »